SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+15.8%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$279M
AUM Growth
+$279M
(+7.1%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-4.39%
Top 10 Holdings %
Top 10 Hldgs %
30.11%
Holding
75
New
11
Increased
17
Reduced
27
Closed
12
Top Buys
| 1 |
HCA Healthcare
HCA
|
$7.65M |
| 2 |
AET
Aetna Inc
AET
|
$7.1M |
| 3 |
Universal Health Services
UHS
|
$7.03M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.75M |
| 5 |
Cardinal Health
CAH
|
$3.24M |
Top Sells
| 1 |
Zoetis
ZTS
|
$4.69M |
| 2 |
Cencora
COR
|
$3.92M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$3.86M |
| 4 |
Molina Healthcare
MOH
|
$3.72M |
| 5 |
Stryker
SYK
|
$3.55M |
Sector Composition
| 1 | Healthcare | 91.74% |
| 2 | Financials | 2.55% |
| 3 | Energy | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
| $9.62M | 3.43% |
30,000
-586
| -2% | -$188K |
|
2
Boston Scientific
BSX
$156B
| $9.05M | 3.23% |
235,000
-25,000
| -10% | -$963K |
|
3
Bristol-Myers Squibb
BMY
$96B
| $8.69M | 3.1% |
140,000
+5,000
| +4% | +$310K |
|
4
Humana
HUM
$36.5B
| $8.57M | 3.06% |
25,300
+300
| +1% | +$102K |
|
5
Merck
MRK
$210B
| $8.51M | 3.04% |
120,000
+13,763
| +13% | +$976K |
|
6
Abbott
ABT
$231B
| $8.44M | 3.01% |
115,000
+20,000
| +21% | +$1.47M |
|
7
Cigna
CI
$80.3B
| $8.33M | 2.97% |
40,000
+15,000
| +60% | +$3.12M |
|
|
8
HCA Healthcare
HCA
$94.5B
| $7.65M | 2.73% |
+55,000
| New | +$7.65M |
|
9
Elevance Health
ELV
$71.8B
| $7.54M | 2.69% |
27,500
+2,500
| +10% | +$685K |
|
10
Eli Lilly
LLY
$657B
| $7.51M | 2.68% |
70,000
-10,000
| -13% | -$1.07M |
|
|
11
Molina Healthcare
MOH
$9.8B
| $7.44M | 2.65% |
50,000
-25,000
| -33% | -$3.72M |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $7.1M | 2.53% |
+35,000
| New | +$7.1M |
|
|
13
Universal Health Services
UHS
$11.6B
| $7.03M | 2.51% |
+55,000
| New | +$7.03M |
|
14
Align Technology
ALGN
$10.3B
| $6.85M | 2.44% |
17,500
+4,500
| +35% | +$1.76M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $6.75M | 2.41% |
35,000
-8,600
| -20% | -$1.66M |
|
16
UnitedHealth
UNH
$281B
| $6.65M | 2.37% |
25,000
+4,427
| +22% | +$1.18M |
|
17
Centene
CNC
$14.3B
| $6.52M | 2.33% |
45,000
-11,100
| -20% | -$1.61M |
|
18
Bio-Rad Laboratories Class A
BIO
$8.06B
| $6.26M | 2.23% |
20,000
+2,500
| +14% | +$783K |
|
19
Biogen
BIIB
$19.4B
| $6.18M | 2.21% |
17,500
-5,000
| -22% | -$1.77M |
|
20
Baxter International
BAX
$12.7B
| $6.17M | 2.2% |
80,000
| – | – |
|
21
Intuitive Surgical
ISRG
$170B
| $6.03M | 2.15% |
10,500
-2,000
| -16% | -$1.15M |
|
22
Illumina
ILMN
$15.8B
| $5.51M | 1.97% |
15,000
| – | – |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.33M | 1.9% |
55,000
-10,000
| -15% | -$970K |
|
|
24
Stryker
SYK
$150B
| $5.33M | 1.9% |
30,000
-20,000
| -40% | -$3.55M |
|
25
Zimmer Biomet
ZBH
$21B
| $5.26M | 1.88% |
40,000
| – | – |
|